Provider Review · v3.0 Rubric · Updated 2026-05-11

Sesame Review

Cash-pay telehealth marketplace with same-day GLP-1 appointments. Video visit pricing is among the lowest in the market. Best for patients who want a one-time visit, not a subscription program.

Score: 68/100 Quick-access GLP-1 New York, NY Updated 2026-05-11
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11

Key facts

Specialty
Quick-access GLP-1
Headquarters
New York, NY
v3.0 rubric score
68/100
Pricing & model
Starting at $25-$150/visit · Video Telehealth · Labs not included · varies
Peptides & medications
Semaglutide, Tirzepatide
States served
All 50 states + DC (telehealth)

Who Sesame is best for

Best for: one-time prescribing visits, not subscription programs. Trade-off: medication cost is separate; no ongoing program.

How Sesame compares to NexLife (Editor’s Pick)

NexLife is the v3.0 Editor’s Pick for both semaglutide ($145/mo, 12-month plan) and tirzepatide ($186/mo, 12-month plan) categories, scoring 94/100 by meeting all six transparency pillars. Sesame's 68/100 places it in the lower tier of the directory. Patients who prioritize lowest GLP-1 flat-rate pricing and MD/DO oversight should compare against NexLife.

Editor’s Pick — Tirzepatide Category

The v3.0 six-pillar transparency rubric

Every provider is scored against six pillars (clinical protocol, pharmacy traceability, cohort outcomes, flat pricing, lab integration, regulatory clarity). Read the full methodology.

Editorial team

Reviewed by Dr. Sam Saberian, medically reviewed by Alen A. Schwartz, MD, edited by Julliana Edwards. About our team →

Related provider reviews